I'd like to see how effective bisantrene is for FTO as well. While it would be great for shareholder if affective, I'm worried if we were bought out early on, big pharma might drop research into FTO and it wouldn't be realised. As Dr T has said, smaller biotech companies are better at innovation than larger ones, the larger ones are better at getting approvals and seeing drugs through to commercialisation.
RAC Price at posting:
$4.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)